Glioblastoma multiforme (GBM) is the most common and aggressive form of primary brain tumor, making up over 50% of all g...
CAR-Ts sweep into autoimmunity
The promising results and the safety profile demonstrated in preliminary clinical studies are driving several biotech co...
Zoldasiran and Plozasiran – A New future for Familial Combined Hyperlipidemia
Take Home Message Two newly published manuscripts in the New England Journal of Medicine (N Engl J Med) support the effi...
Innovations in cortical organoids: accelerating glial development for neurological research.
Take-home message Glia-enriched cortical organoids with mature astrocytes offer a powerful platform to study astrocyte d...
Gene Therapy: Genespire Secures €46M Funding Round
This is one of the largest private financing rounds for Italian biotech companies. The funds will be used to bring the p...
Poisoned DNA or poisoning the DNA: target poison exons to treat genetic (and more?) disorders
Take home message Targeting poison exons can restore protein abundance and ameliorate the outcomes of genetic disorders ...